$310 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 53 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 41.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $30,218,000 | +26.0% | 389,000 | -10.4% | 9.76% | +22.3% |
| BIIB | Sell | Biogen Inc | $12,349,000 | -7.3% | 43,600 | -14.8% | 3.99% | -10.0% |
| AMGN | Sell | Amgen Inc | $11,175,000 | -7.2% | 44,000 | -15.4% | 3.61% | -9.9% |
| ALXN | Sell | Alexion Pharmaceuticals Inc | $8,601,000 | -12.4% | 75,241 | -14.7% | 2.78% | -14.9% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $4,462,000 | -11.3% | 26,900 | -38.7% | 1.44% | -13.9% |
| IMMU | Sell | IMMUNOMEDICS INC | $4,224,000 | -72.5% | 49,700 | -88.9% | 1.36% | -73.2% |
| CCXI | Sell | CHEMOCENTRYX INC | $1,292,000 | -87.7% | 23,600 | -87.7% | 0.42% | -88.0% |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -27,000 | -100.0% | -0.32% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -23,100 | -100.0% | -0.43% | – |
| SAGE | Exit | Sage Therapeutics Inc | $0 | – | -37,600 | -100.0% | -0.52% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -46,500 | -100.0% | -0.76% | – |
| ZGNX | Exit | Zogenix Inc | $0 | – | -236,832 | -100.0% | -2.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-12-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.